Background: Toxoplasma gondii is classified as intracellular protozoa and is one of the major zoonotic parasites. Most warm-blooded intermediate hosts, including humans, are commonly infected by this parasite. The epidemiology of T. gondii infection in Egyptian horses is currently poorly understood. Methods: 420 blood samples were randomly collected from horses raised in four governorates in Northern Egypt (110 each from Giza and Kafr El Sheikh, and 100 each from Qalyubia and Gharbia) to investigate the existence of antibodies against T. gondii using a commercial ELISA kit, and to ascertain the risk factors for the infection. Results: the antibodies for T. gondii were found in 16.2% (68/420) of the examined horses, with no significant differences among the four studied governorates. The highest prevalence rate was observed in Giza. The results revealed that sex, breed, age, and contact with domestic ruminants or cats were recognized as potential risk factors. The high prevalence rate was found in mixed breed horses (OR = 2.63, 95% CI: 0.95–7.26), mares (OR = 2.35, 95% CI: 1.31–4.19), and horses aged over 10 years (OR = 2.78, 95% CI: 1.30–3.44). Moreover, the likelihood of seropositivity for T. gondii infection was higher in horses raised in environments with cats (OR = 1.97, 95% CI: 1.13–3.44, p = 0.017) or domestic ruminants (OR = 2.16, 1.21–3.86, p = 0.010). This report confirms that horses in Northern Egypt are exposed to T. gondii and thus raises the possibility that people and other animals could contract the disease. Conclusions: routine examination and management of T. gondii infection in horses in these governorates is advised.

Concerns regarding the possible hazards to human health have been raised by the growing usage of silica nanoparticles (SiNPs) in a variety of applications, including industrial, agricultural, and medical applications. This in vivo subchronic study was conducted to assess the following: (1) the toxicity of orally administered SiNPs on the liver, kidneys, and adrenal glands; (2) the relationship between SiNPs exposure and oxidative stress; and (3) the role of magnesium in mitigating these toxic effects. A total of 24 Sprague Dawley male adult rats were divided equally into four groups, as follows: control group, magnesium (Mg) group (50 mg/kg/d), SiNPs group (100 mg/kg/d), and SiNPs+ Mg group. Rats were treated with SiNPs by oral gavage for 90 days. The liver transaminases, serum creatinine, and cortisol levels were evaluated. The tissue malondialdehyde (MDA) and reduced glutathione (GSH) levels were measured. Additionally, the weight of the organs and the histopathological changes were examined. Our results demonstrated that SiNPs exposure caused increased weight in the kidneys and adrenal glands. Exposure to SiNPs was also associated with significant alterations in liver transaminases, serum creatinine, cortisol, MDA, and GSH. Additionally, histopathological changes were significantly reported in the liver, kidneys, and adrenal glands of SiNPs-treated rats. Notably, when we compared the control group with the treated groups with SiNPs and Mg, the results revealed that magnesium could mitigate SiNPs-induced biochemical and histopathologic changes, confirming its effective role as an antioxidant that reduced the accumulation of SiNPs in tissues, and that it returns the levels of liver transaminases, serum creatinine, cortisol, MDA, and GSH to almost normal values.

No abstract